Chin, MKY; Hsia, Y; Goossens, H; Versporten, A; Bielicki, J; Sharland, M; Donà, D
(2020)
Evidence of Dose Variability and Dosing Below the FDA and EMA Recommendations for Intravenous Colistin (Polymyxin E) Use in Children and Neonates.
Pediatr Infect Dis J, 39 (11).
pp. 1032-1034.
ISSN 1532-0987
https://doi.org/10.1097/INF.0000000000002847
SGUL Authors: Hsia, Yingfen
|
PDF
Accepted Version
Available under License ["licenses_description_publisher" not defined]. Download (1MB) | Preview |
Abstract
Intravenous colistin (polymyxin E) has renewed interest as a last-line treatment against antimicrobial-resistant gram-negative bacterial infections, despite limited literature on pediatric prescribing practices. Point-prevalence surveys were used to obtain intravenous colistin prescribing data from 78 children and neonates, showing high variability, and 60.3% received doses below the Food and Drug Administration and the European Medicines Agency recommendations.
| Item Type: | Article |
|---|---|
| Additional Information: | This is a non-final version of an article published in final form in Chin, MKY; Hsia, Y; Goossens, H; Versporten, A; Bielicki, J; Sharland, M; Donà, D (2020) Evidence of Dose Variability and Dosing Below the FDA and EMA Recommendations for Intravenous Colistin (Polymyxin E) Use in Children and Neonates. Pediatr Infect Dis J, 39 (11). pp. 1032-1034. |
| Keywords: | Pediatrics, 1114 Paediatrics and Reproductive Medicine |
| SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) |
| Journal or Publication Title: | Pediatr Infect Dis J |
| ISSN: | 1532-0987 |
| Language: | eng |
| Publisher License: | Publisher's own licence |
| PubMed ID: | 32773667 |
 |
Go to PubMed abstract |
| URI: | https://openaccess.sgul.ac.uk/id/eprint/112308 |
| Publisher's version: | https://doi.org/10.1097/INF.0000000000002847 |
Statistics
Actions (login required)
 |
Edit Item |